市場調查報告書
商品編碼
603200

全球手術用人工血管市場:各種類、聚合物類型、地區(2017年∼2022年)

Artificial Blood Vessels Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球手術用人工血管市場相關調查,市場概要,各種類、聚合物類型、地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素以及市場機會、威脅分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 報告的說明
  • 調查方法

第2章 摘要整理

第3章 市場概要

  • 市場定義
  • 市場成長要素
    • 最小限度的副作用
    • 長的品質保持期限
  • 市場阻礙因素
    • 捐獻
    • 篩檢
    • 成本規定
  • 市場機會
  • 市場威脅

第4章 波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第5章 全球手術用人工血管市場:市場區隔

  • 各類型
    • 全氟碳化合物
    • 血紅素為基礎的氧載體
  • 各類聚合物
    • 合成橡膠
    • Polydioxanone
    • 聚乙烯對苯二甲酸酯
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區

第6章 競爭情形

  • 合併、收購
  • 合作,協定,夥伴關係
  • 新產品的銷售
  • 對新加入企業的建議

第7章 公司簡介

  • ArtiCasc 3D
  • Techshot Inc
  • Humacyte Inc.

第8章 附錄

  • 免責聲明
  • 參考文獻
  • 參考資料
  • 簡稱
目錄
Product Code: 51984

The people are facing problems of blocked blood vessels that can cause some extreme life-threatening conditions. Hence, it is essential to replace a damaged blood vessel either by artificial vascular prostheses or through another arteries or veins from the body. The research institutes have thus developed artificial blood vessels made from special polymers, that has exceptional mechanical properties.

Surgeons initially transplanted veins or arteries from donors to replace the damaged or diseased arteries from human body. Transplanting vessels from the patient's own body has various problems such as, development of arteriosclerosis and several post-surgery complications. Hence, to avoid such difficulties, artificial blood vessels were created by researchers, thus augmenting market growth.

However, presence of a stringent regulatory framework for the approval of artificial vessels will limit market growth. Moreover, high cost associated with transplants and surgeries will further impede market growth.

Key Market Trends

Application in Aortic Disease is Expected to cover a Large Share of the Market

The aorta is the largest artery in the body. Oxygen-rich blood enters the aorta and the heart pumps the blood out of the aorta where it travels to the rest of the body via the smaller arteries that branch out from it. A variety of diseases and conditions can cause damage to the aorta and put patients at great, life-threatening risk. Those conditions include atherosclerosis, hypertension, genetic conditions, connective tissue disorders, and injury.

As per a report 2015 report by D. P. J. Howard et al., published in Wiley Online Library, the incidence of acute abdominal aortic aneurysm (AAA) events per 100 000 population per year was 55 in men aged between 65 and 74 years, but increased to 112 at age between 75 and 84 years and to 298 at age 85 years or above. Therefore as the geriatric population is increasing as per 2017 report on "World Aging Population" by the United Nations. Hence, the prevalence of aortic diseases is expected to increase in the future.

When aneurysm ruptures, surgery is needed. Surgery thus involves removing the section of aorta where the aneurysm is and replacing it with an artificial blood vessel. Therefore with the increasing incidence, artificial blood vessels application is expected to increase and this in turn will help the market growth.

North America is Expected to Dominate the Artificial Blood Vessels Market

North America holds the major share of the market due to well-developed healthcare infrastructure, and technology advancements in this region.

Besides, growing prevalence of aortic diseases in the U.S. is also likely to boost market growth. As per Center for Diseases Control and Prevention 2019 report, aortic aneurysms were the cause of 9,928 deaths in 2017 in the United States. The number of smokers, who are more prone to aortic diseases are also incresing in the US.Hence, growing burden of such diseases will augment the artificial blood vessels market.

However, the United States also have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the artificial blood vessels are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Aortic Diseases
    • 4.2.2 Growing Adoption of Minimally Invasive Surgeries
    • 4.2.3 Technoloigical Advancements in Development of Artificial Blood Vessels
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with Transplants and Surgeries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Aortic Disease
    • 5.1.2 Peripheral Artery Disease
    • 5.1.3 Hemodialysis
  • 5.2 By Polymer
    • 5.2.1 Polydioxanone
    • 5.2.2 Elastomer
    • 5.2.3 Polyethylene Terephthalate
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Cook Medical Incorporated
    • 6.1.4 Humacyte Inc.
    • 6.1.5 Jotec GmbH
    • 6.1.6 LeMaitre Vascular Inc
    • 6.1.7 Medtronic
    • 6.1.8 Techshot Inc
    • 6.1.9 Terumo Medical Corporation
    • 6.1.10 W. L. Gore and Associates

7 MARKET OPPORTUNITIES AND FUTURE TRENDS